Log In
Print this Print this

NovoMix 30

Also known as: Novolog Mix 70/30

  Manage Alerts
Collapse Summary General Information
Company Novo Nordisk A/S
DescriptionMix of 70% insulin aspart protamine suspension and 30% insulin aspart injection
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsTreat patients with Type II diabetes who are new to insulin therapy; Treat Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today